Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.

Benech, N.; Cassir, N.; Galperine, T.; Alric, L.; Scanzi, J.; Sokol, H.

doi:10.1053/j.gastro.2024.04.022

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.

Details

Request a copy

Serval ID

serval:BIB_22B215888B2C

Type

Article: article from journal or magazin.

Publication sub-type

Case report (case report): feedback on an observation with a short commentary.

Collection

Publications

Institution

UNIL/CHUV

Title

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.

Journal

Gastroenterology

Author(s)

Benech N., Cassir N., Galperine T., Alric L., Scanzi J., Sokol H.

Working group(s)

French Fecal Transplant Group

Contributor(s)

Benech N., Cassir N., Alric L., Melchior C., Mosca A., Joly A.C., Kapel N., Barbut F., Galperine T., Pigneur B., Davido B., Schneider S., Briot T., Wasiak M., Nebad B., Batista R., Mosca A., Bleibtreu A., Scanzi J., Sokol H., Sintes R., Corriger A., Flet L., Perlemuter G., Ahloulay M., Yaye H.S., De Rougemont A., Olivier E., Burucoa C., Gobert J.G., Landman C., Vignal L., Joly F., Ravinet A., Bellanger A., Sabate J.M., Humbert C., Wisnewsky J.A., Charpentier C., Moreno-Sabater A., Takoudju C., Poirier P., Tanne F., De Lastours V., Stampfli C.

ISSN

1528-0012 (Electronic)

ISSN-L

0016-5085

Publication state

Published

Issued date

08/2024

Peer-reviewed

Oui

Volume

167

Number

3

Pages

627-628

Language

english

Notes

Publication types: Journal Article ; Case Reports ; Letter
Publication Status: ppublish

Keywords

Humans, Fecal Microbiota Transplantation/adverse effects, Immunocompromised Host, Clostridium Infections/therapy, Clostridium Infections/diagnosis, Clostridium Infections/microbiology, Clostridium Infections/immunology, Clostridioides difficile, Risk Assessment, Recurrence, Male, Female, Treatment Outcome, Middle Aged, Aged

OAI-PMH

oai:serval.unil.ch:BIB_22B215888B2C

DOI

10.1053/j.gastro.2024.04.022

Pubmed

38679396

Web of science

001276926100001

Open Access

Yes

Create date

03/05/2024 15:12